The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Novobiocin and Related Coumarins and Depletion of Heat Shock Protein 90-Dependent Signaling Proteins
Abstract
BACKGROUND: Heat shock protein 90 (Hsp90) interacts with and stabilizes several oncogenic protein kinases (e.g., p185(erbB2), p60(v-src), and Raf-1) and is required for the stability and dominant-negative function of mutated p53 protein. Two unrelated antibiotics, geldanamycin and radicicol, bind specifically to an atypical nucleotide-binding pocket of Hsp90, a site that shares homology with the adenosine triphosphate (ATP)-binding domain of bacterial DNA gyrase B. This interaction leads to destabilization of proteins that interact with Hsp90. Since the nucleotide-binding site of gyrase B is targeted by coumarin antibiotics (e.g., novobiocin), we investigated whether these drugs can also interact with Hsp90 and affect its activity. METHODS: We used immobilized novobiocin, geldanamycin, or radicicol to isolate either endogenous Hsp90 from cell lysates or Hsp90 deletion fragments translated in vitro. Effects of the coumarin antibiotics novobiocin, chlorobiocin, and coumermycin A1 on several proteins interacting with Hsp90 were assessed in vitro and in vivo. RESULTS: Hsp90 binding to immobilized novobiocin was competed by soluble coumarins and ATP but not by geldanamycin or radicicol. A carboxy-terminal Hsp90 fragment bound immobilized novobiocin but not immobilized geldanamycin, while a geldanamycin-binding amino-terminal fragment did not bind novobiocin. All three coumarins markedly reduced cellular levels of p185(erbB2), p60(v-src), Raf-1, and mutated p53. Furthermore, novobiocin reduced Raf-1 levels in the spleens of mice treated with the drug. CONCLUSIONS: These coumarin antibiotics, particularly novobiocin, represent a first-generation alternative to other Hsp90-targeting drugs that are not as well tolerated. Novobiocin's unique interaction with Hsp90 identifies an additional site on this protein amenable to pharmacologic interference with small molecules.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cobleigh, M. A., Vogel, C. L., Tripathy, D., Robert, N. J., Scholl, S., Fehrenbacher, L., Wolter, J. M., Paton, V., Shak, S., Lieberman, G., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2639 · Cited by 2,765
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Self-citationStebbins, C. E., Russo, A. A., Schneider, C., Rosen, N., Hartl, F. U., & Pavletich, N. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80203-2 · Cited by 1,364
Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80314-1 · Cited by 1,265
The Biology of heat shock proteins and molecular chaperones.
Morimoto, R. I., Tissieres, A., & Georgopoulos, C. P. (1994) · Cold Spring Harbor Laboratory eBooks · Cited by 1,243
The 90-kDa Molecular Chaperone Family
Csermely, P., Schnaider, T., So″ti, C., Prohászka, Z., & Nardai, G. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00013-8 · Cited by 1,028
An atypical topoisomerase II from archaea with implications for meiotic recombination
Bergerat, A., de Massy, B., Gadelle, D., Varoutas, P.-C., Nicolas, A., & Forterre, P. (1997) · Nature · doi:10.1038/386414a0 · Cited by 945
Grenert, J. P., Sullivan, W. P., Fadden, P., Haystead, T. A. J., Clark, J., Mimnaugh, E., Krutzsch, H., Ochel, H.-J., Schulte, T. W., Sausville, E., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23843 · Cited by 569
Self-citationCatelli, M. G., Binart, N., Jung-Testas, I., Renoir, J. M., Baulieu, E. E., Feramisco, J. R., & Welch, W. J. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04055.x · Cited by 516
Sanchez, E. R., Toft, D. O., Schlesinger, M. J., & Pratt, W. B. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38886-5 · Cited by 482
Mimnaugh, E. G., Chavany, C., & Neckers, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22796 · Cited by 466
Self-citationSchulte, T. W., Blagosklonny, M. V., Ingui, C., & Neckers, L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24585 · Cited by 456
Self-citationUnusual expression and localization of heat‐shock proteins in human tumor cells
Ferrarini, M., Heltai, S., Zocchi, M. R., & Rugarli, C. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510418 · Cited by 432
Schulte, T. W., Akinaga, S., Soga, S., Sullivan, W., Stensgard, B., Toft, D., & Neckers, L. M. (1998) · Cell Stress & Chaperones · doi:10.1379/1466-1268(1998)003<0100:arbttn>2.3.co;2 · Cited by 403
Self-citationLewis, R. J., Singh, O. M., Smith, C. V., Skarzynski, T., Maxwell, A., Wonacott, A. J., & Wigley, D. B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00483.x · Cited by 335
Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90.
Blagosklonny, M. V., Toretsky, J., Bohen, S., & Neckers, L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8379 · Cited by 314
Self-citationStancato, L. F., Chow, Y. H., Hutchison, K. A., Perdew, G. H., Jove, R., & Pratt, W. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80600-0 · Cited by 300
Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol
Sharma, S. V., Agatsuma, T., & Nakano, H. (1998) · Oncogene · doi:10.1038/sj.onc.1201790 · Cited by 277
The native structure of the activated Raf protein kinase is a membrane-bound multi-subunit complex.
Wartmann, M., & Davis, R. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37431-8 · Cited by 261
p185erbB2 Binds to GRP94 in Vivo
Chavany, C., Mimnaugh, E., Miller, P., Bitton, R., Nguyen, P., Trepel, J., Whitesell, L., Schnur, R., Moyer, J. D., & Neckers, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.4974 · Cited by 257
Self-citationNucleotides and Two Functional States of hsp90
Sullivan, W., Stensgard, B., Caucutt, G., Bartha, B., McMahon, N., Alnemri, E. S., Litwack, G., & Toft, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.8007 · Cited by 238
Binding of p23 and hsp90 during assembly with the progesterone receptor.
Johnson, J. L., & Toft, D. O. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.6.8592513 · Cited by 233
Interaction of the Rous Sarcoma Virus Protein pp60 src with the Cellular Proteins pp50 and pp90
Brugge, J. S. (1986) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-70810-7_1 · Cited by 224
Geldanamycin selectively destabilizes and conformationally alters mutated p53.
Blagosklonny, M. V., Toretsky, J. A., & Neckers, L. (1995) · PubMed · Cited by 202
Self-citationWilhelmsson, A., Cuthill, S., Denis, M., Wikström, A. C., Gustafsson, J. A., & Poellinger, L. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08081.x · Cited by 198
Sepp-Lorenzino, L., Ma, Z., Lebwohl, D. E., Vinitsky, A., & Rosen, N. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16580 · Cited by 189
Interaction of Radicicol with Members of the Heat Shock Protein 90 Family of Molecular Chaperones
Schulte, T. W. (1999) · Molecular Endocrinology · doi:10.1210/me.13.9.1435 · Cited by 161
Self-citationHartson, S. D., Thulasiraman, V., Huang, W., Whitesell, L. J., & Matts, R. L. (1999) · Biochemistry · doi:10.1021/bi983027s · Cited by 84
Song, Z.-F., Xie, W., Shan, H.-M., Guo, X.-H., & Sun, B. (2006) · PubMed · doi:10.1101/087969427.26.313 · Cited by 66
Mutational analysis of hsp90 binding to the progesterone receptor.
Sullivan, W. P., & Toft, D. O. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80738-8 · Cited by 63
Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model.
Eder, J. P., Teicher, B. A., Holden, S. A., Cathcart, K. N. S., & Schnipper, L. E. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112983 · Cited by 45
Steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combination
Drusano, G. L., Townsend, R. J., Walsh, T. J., et al. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.1.42 · Cited by 40
Neckers, L., Mimnaugh, E. G., & Schulte, T. W. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-58259-2_2 · Cited by 30
Self-citation
Cited by
HSP90 and the chaperoning of cancer
Whitesell, L., & Lindquist, S. L. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1716 · Cited by 2,502
Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
Neckers, L., & Workman, P. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1000 · Cited by 891
Self-citationChang, F., Steelman, L. S., Lee, J. T., Shelton, J. G., Navolanic, P. M., Blalock, W. L., Franklin, R. A., & McCubrey, J. A. (2003) · Leukemia · doi:10.1038/sj.leu.2402945 · Cited by 725
The HSP90 Family: Structure, Regulation, Function, and Implications in Health and Disease
Hoter, A., El-Sabban, M. E., & Naim, H. Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092560 · Cited by 693
Hsp90 inhibitors as novel cancer chemotherapeutic agents
Neckers, L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02316-x · Cited by 677
Self-citation
Metadata
- Authors
- Marcu, M. G., Schulte, T. W., & Neckers, L.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-02-02
- Volume
- 92
- Issue
- 3
- Pages
- 242-248
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2134175129
- Cited by
- 405
- References
- 33
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.